Skip to main content

Utility Menu

  • Heart Failure Awareness Week
  • COVID-19
  • Meetings
  • News
  • Journal
  • Learning Center
  • Member Login
Home

Main navigation

  • About Us
    • Board of Directors
    • Committees
    • Event Endorsement Guidelines
    • Financials
    • HFSA Staff
    • Sponsorship
    • Strategic Plan
  • Membership
    • Join or Renew
    • Membership Benefits and Types
    • Membership Directory
    • Member Login
    • Corporate Membership
  • Professional Development
    • Awards
    • Continuing Education
      • HFSA Virtual Annual Scientific Meeting 2020
      • HFSA Virtual Board Certification Review 2020
    • Heart Failure Certification (HF-Cert)
    • Fellowship Designation Program (FHFSA)
    • ERAS/NRMP Match for AHFTC Fellowship
    • HFSA Career Center
    • HFSA Learning Center
    • Heart Failure Beat Podcast
    • Professional Development News
  • Research
    • Heart Failure Beat Podcast
    • Journal of Cardiac Failure
    • Published Papers & Guidelines
    • Surveys
    • HFSA Research Network
    • Industry News
  • Advocacy
  • Patient Hub
    • Additional Resources for Patients
    • Heart Failure Awareness 365
    • Heart Failure Beat Healthy Living Podcast
    • Heart Failure Clinical Trials Search
    • Heart Failure Facts
    • Heart Failure Patient and Caregiver Day 2020
    • Patient News
    • Patient Tools
    • Patient Resources for Providers
    • HFSA Coronavirus (COVID-19) Resources
  • Coronavirus (COVID-19) Resources
  • Heart Failure Awareness Week
  • COVID-19
  • Meetings
  • News
  • Journal
  • Learning Center
  • Member Login
Facebook
Youtube
Twitter
Linkedin

Breadcrumb

  1. Home
  2. News

News

Oct
5
2020 |

Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash

Industry News
In The News
Industry
Read More
Sep
2
2020 |

Jardiance® reduced the combined relative risk of cardiovascular death and hospitalization for heart failure by 25% in adults with and without diabetes who had heart failure with reduced ejection fraction

Industry News
Industry
Read More
Sep
1
2020 |

Farxiga demonstrated unprecedented reduction in the risk of kidney failure and cardiovascular or renal death in patients with chronic kidney disease in the Phase III DAPA-CKD trial

Industry News
Industry
Read More
Jul
30
2020 |

Jardiance® meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes

Industry News
Industry
Read More
Jul
15
2020 |

Update on Merck's New Scientific Efforts to Help Combat COVID-19

Industry News
Industry
Read More

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page Next ›
  • Last page Last »

Leading experts on heart failure care

Our vision is to significantly reduce the burden of heart failure and provide a platform for collaboration, education, innovation, research, and advocacy to improve and expand care.

Learn more About HFSA

Get in touch

9211 Corporate Blvd., Suite 270 Rockville, MD 20850
(301) 312-8635
info@hfsa.org
Facebook
Youtube
Twitter
Linkedin

Footer menu

  • Contact
  • Media Center
  • Privacy Policy & Terms of Use